Labcorp is expanding its global BioPharmaceutical Chemistry, Manufacturing and Control (CMC) footprint and is opening a new, purpose-built CMC facility in Mechelen, Belgium. This site has been strategically developed to complement our existing capabilities in York and Harrogate (UK), and Greenfield (US). With a strong portfolio of clients and over 25 years of expertise this team provides advanced characterization, method development, stability and routine QC release for biologics, vaccines, ATMP's, and a breadth of other complex biomolecules. With this new laboratory in Belgium, we aim to offer a more comprehensive solution and accelerate the availability of new products for patients. This expansion is a key milestone in our long-term plan to strengthen support for pharmaceutical and biotechnology partners who rely on Labcorp for complex CMC, bioanalytical, and regulatory testing services.
plus